Physician profile
Peter Elia Smith
NPI 1386020832
$4,498.99
in general payments reported to CMS, 2019-2025
27 companies · $1,635 in 2025
The $1,635 reported for 2025 was more than what 80% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $114 · 2023: $1,154 · 2024: $1,442 · 2025: $1,635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,230.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $876.68 | 2023-2025 | Grafix, Stravix, Grafix Xc |
| Bioventus LLC | $459.33 | 2023-2025 | Exogen Ultrasound Bone Healing System, Stimrouter Implantable Kit, Bonescalpel & Sonicone (O.R.) |
| Treace Medical Concepts, INC. | $412.12 | 2023-2025 | |
| Orthofix Medical, INC. | $379.67 | 2023-2024 | Ankle Hindfoot Nailing System, Truelok, Tl-Hex Truelok Hexapod System |
| Stryker Corporation | $340.62 | 2019-2025 | Bioskin, Allograft Bio-Implants, Citrefix |
| Mimedx Group, INC. | $298.09 | 2024-2025 | |
| Trilliant Surgical LLC. | $264.11 | 2019-2024 | Minimally Invasive Bunion Plate, Left |
| Organogenesis INC. | $262.65 | 2023-2025 | Via Matrix, Affinity |
| Convatec INC. | $181.73 | 2023 | |
| Horizon Therapeutics Plc | $164.60 | 2023 | Krystexxa |
| Forma Medical | $143.69 | 2025 | Optimalmtp |
| Medtronic, INC. | $133.34 | 2024 | Closurefast |
| Novus Surgical Consultants | $100.00 | 2024 | |
| Averitas Pharma INC. | $95.82 | 2023-2025 | Qutenza |
| Sanara Medtech INC. | $92.98 | 2025 | Celleraterx |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $63.96 | 2023 | Motoband |
| Globus Medical, INC. | $45.59 | 2025 | Senza |
| Nevro Corp. | $28.64 | 2024 | Senza |
| Amgen INC. | $28.23 | 2024 | Krystexxa |
| Omeza LLC | $24.26 | 2024 | |
| Paratek Pharmaceuticals, INC. | $23.57 | 2023 | Nuzyra |
| Solventum Corporation | $17.17 | 2025 | Activ.A.C., V.A.C. Granufoam, 3m Cavilon |
| Biotissue Holdings INC. | $17.15 | 2020 | |
| Kerecis Limited | $13.77 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Hydrofera LLC | $13.21 | 2023 | Hydrofera Blue |
| Alafair Biosciences, INC. | $9.18 | 2025 | Versawrap |
| Ermi LLC | $8.83 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.